ESR Digital, AI, and Emerging Technologies Committee Session
ESR DAET 12 - Emerging contrast agents and radiotracers
Lectures
1
Chairpersons' introduction
03:00Laurie A. Loevner, Philadelphia / US, Aart J. Van Der Molen, Leiden / NL
2
High-relaxivity gadolinium-based contrast agents: when do these add value?
19:00Giles Hannibal Roditi, Glasgow / UK
3
Short-chain fatty acid metabolism (FPIA) PET imaging: bench to bedside
19:00Eric Aboagye, London / UK
4
Seeing beyond structure: the clinical potential of metabolic MRI
19:00Christoffer Laustsen, Aarhus / DK
3 min
Chairpersons' introduction
Aart J. Van Der Molen, Leiden / Netherlands
Laurie A. Loevner, Philadelphia / United States
Laurie A. Loevner, Philadelphia / United States
19 min
High-relaxivity gadolinium-based contrast agents: when do these add value?
Giles Hannibal Roditi, Glasgow / United Kingdom
- To learn about currently available high-relaxivity GBCA.
- To appreciate the benefits of HR-GBCA in daily practice.
- To understand the indications for which there is added value.
19 min
Short-chain fatty acid metabolism (FPIA) PET imaging: bench to bedside
Eric Aboagye, London / United Kingdom
- To learn the development of short-chain fatty acid [18F]fluoropivalate (FPIA) PET imaging.
- To appreciate the clinical potential for FPIA imaging of brain tumours (gliomas and metastatic tumours).
- To understand future prospects for FPIA imaging and image-guided therapy (theranostics).
19 min
Seeing beyond structure: the clinical potential of metabolic MRI
Christoffer Laustsen, Aarhus / Denmark
- To learn about metabolic MRI techniques, including hyperpolarised ¹³C MRI and deuterium metabolic imaging (DMI) and their potential applications in oncology, neurology, and other areas.
- To appreciate the technical challenges in translating metabolic MRI from research into routine clinical use, including data acquisition, post-processing, and interpretation.
- To understand the current clinical evidence supporting metabolic MRI, its advantages over conventional imaging methods.